发明名称 MODIFIED ORGANS AND CELLS FOR XENOTRANSPLANTATION
摘要 It has been discovered that there are at least two significant antigens present on the cells of animal species such as pigs that elicit an immune or inflammatory response immediately upon implantation into humans or contact with human serum. The first is anα-galactosyl (Gal) epitope, for example, Galα(1->3)Galβ(1->4)GlcNac (linear B type 2) or Galα(1->3)Galβ(1->4)Glc (linear B type 6). The second is an N-glycolylneuraminic acid (NeuGc) structure. By eliminating these epitopes, preferably by genetically engineering the animal so that the epitope is either not produced or is greatly reduced. or by chemical or enzymatic treatment of the animal's cells to remove the epitopes, it is possible to produce organs, tissues and cells suitable for xenotransplantation into humans. Cells can be rendered even more compatible by genetically engineering the animal to express a human complement regulatory protein (inhibitor), such as CD59, on its cells, or to express an excess of a pig complement regulatory protein.
申请公布号 US2011301341(A1) 申请公布日期 2011.12.08
申请号 US201113211040 申请日期 2011.08.16
申请人 ZHU ALEX;RBC BIOTECHNOLOGY, INC. 发明人 ZHU ALEX
分类号 C07K14/435;A01K67/027;A61K35/12;A61K35/18;A61L27/00;C07K1/00;C07K14/47;C12N5/10;C12N15/09;C12P21/02 主分类号 C07K14/435
代理机构 代理人
主权项
地址